Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2)

Showing 2 of 2 trials
NCT05243654Phase 2Recruiting

Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy

Role: collaborator

NCT06441981Not ApplicableRecruiting

Public Perception and Policy for SARS-CoV-2 Whole Genome Sequencing and Genomics for All

Role: collaborator

All 2 trials loaded